Ouro Fino Saúde Animal Participações Third Quarter 2023 Earnings: EPS: R$0.077 (vs R$0.83 in 3Q 2022)

Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Third Quarter 2023 Results

Key Financial Results

• Revenue: R$263.7m (down 6.1% from 3Q 2022).
• Net income: R$4.12m (down 91% from 3Q 2022).
• Profit margin: 1.6% (down from 16% in 3Q 2022).
• EPS: R$0.077 (down from R$0.83 in 3Q 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ouro Fino Saúde Animal Participações Earnings Insights

Looking ahead, revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the Global Pharmaceuticals industry.

Performance of the market in Brazil.

The company's shares are up 2.4% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. See our latest analysis on Ouro Fino Saúde Animal Participações' balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.